MACROLIFE NATURALS, INC. – Trademark Portfolio
Entity Type: 03
MACROLIFE NATURALS, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include MACROMEAL, MACRO PETS, MACRO GREENS, MIRACLE REDS, and MACROLIFE NATURALS. The owner is based in Los Angeles, CA.
10573 W Pico Blvd Box # 252
Los Angeles, CA 90064
Showing of trademarks Trademarks
Trademark Classifications
MACROLIFE NATURALS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does MACROLIFE NATURALS, INC. have?
MACROLIFE NATURALS, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned, 2 cancelled.
What trademark classes does MACROLIFE NATURALS, INC. file in?
MACROLIFE NATURALS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MACROLIFE NATURALS, INC.'s most well-known trademarks?
MACROLIFE NATURALS, INC.'s registered trademark portfolio includes well-known marks such as MACROMEAL, MACRO PETS, MACRO GREENS, MIRACLE REDS, and MACROLIFE NATURALS. These are among 5 currently registered trademarks in the portfolio.
What is MACROLIFE NATURALS, INC.'s trademark registration success rate?
MACROLIFE NATURALS, INC. has a 50% trademark registration rate, with 5 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.